These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 4255254

  • 1. 5-hydroxytryptophan (5-HTP) in Down's syndrome.
    Partington MW, MacDonald MR.
    Dev Med Child Neurol; 1971 Jun; 13(3):362-72. PubMed ID: 4255254
    [No Abstract] [Full Text] [Related]

  • 2. The use of 5-HTP in the treatment of Down's syndrome.
    Weise P, Koch R, Shaw KN, Rosenfeld MJ.
    Pediatrics; 1974 Aug; 54(2):165-8. PubMed ID: 4277102
    [No Abstract] [Full Text] [Related]

  • 3. Tryptophan treatment of infants with Down's syndrome.
    Airaksinen EM.
    Ann Clin Res; 1974 Feb; 6(1):33-9. PubMed ID: 4274411
    [No Abstract] [Full Text] [Related]

  • 4. 5-hydroxyindole levels in the blood and CSF in Down's syndrome, phenylketonuria and severe mental retardation.
    Tu J, Partington MW.
    Dev Med Child Neurol; 1972 Aug; 14(4):457-66. PubMed ID: 4262081
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Platelet-rich plasma 5-hydroxytryptamine, urinary 5-hydroxyindoleacetic acid and tryptophan ingestion in mongols.
    Airaksinen EM.
    J Ment Defic Res; 1971 Dec; 15 Pt 4(0):244-56. PubMed ID: 4279295
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations.
    Bazelon M, Barnet A, Lodge A, Shelburne SA.
    Brain Res; 1968 Nov; 11(2):397-411. PubMed ID: 4302675
    [No Abstract] [Full Text] [Related]

  • 9. 5-Hydroxytryptophan and sleep in Down's syndrome.
    Petre-Quadens O, De Lee C.
    J Neurol Sci; 1975 Nov; 26(3):443-53. PubMed ID: 171348
    [Abstract] [Full Text] [Related]

  • 10. Infantile spasms associated with 5-hydroxytryptophan administration in patients with Down's syndrome.
    Coleman M.
    Neurology; 1971 Sep; 21(9):911-9. PubMed ID: 4328302
    [No Abstract] [Full Text] [Related]

  • 11. Catabolism of serotonin in Down's syndrome (tisomy 21).
    Kamoun P, Lafourcade G, Jerome H.
    Biomedicine; 1974 Oct 10; 21(10):426-8. PubMed ID: 4281668
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sleep EEG patterns in a case of Down's syndrome--before and after 5-HTP.
    Lee JC, Ornitz EM, Tanguay PE, Ritvo ER.
    Electroencephalogr Clin Neurophysiol; 1969 Sep 10; 27(7):686. PubMed ID: 4187354
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome.
    Castells S, Chakrabarti C, Winsberg BG, Hurwic M, Perel JM, Nyhan WL.
    J Autism Dev Disord; 1979 Mar 10; 9(1):95-103. PubMed ID: 312282
    [Abstract] [Full Text] [Related]

  • 19. Letter: 5-hydroxyindoleacetic acid in Down's syndrome.
    Adlard BP, De Souza SW, Tricklebank MD.
    Lancet; 1974 May 11; 1(7863):936. PubMed ID: 4133464
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.